LifeSigns raises Pre-Series A

A funding to expand operations and provide better patient care

Alpla and Inden pharma form joint venture

ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma

Pfizer acquires Seagen for US$ 43 billion to battle cancer

Proposed combination enhances Pfizer’s position as a leading company in oncology

Dr. Lal PathLabs selects Kyndryl for cloud services management

Kyndryl's multi-cloud management solution leverages AI-based, cloud-hosted models to provide real-time metrics, events, logs, and traces

Precision appoints John Hubbard, PhD, as Board of Directors Chair

Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.

Shilpa Medicare gets 2 minor observations from USFDA for Unit VII, Analytical Services Division

The company will be submitting the responses to US FDA observations within stipulated timeline

Zydus receives final approval from the USFDA for Olanzapine

Olanzapine Orally Disintegrating Tablets are used to treat certain mental/mood conditions

IIT Kanpur and Reliance Life Sciences join forces to revolutionize gene therapy for hereditary eye diseases

IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases

NATCO launches additional strengths for generic version of Revlimid in USA

Lenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.

Alembic receives USFDA tentative approval for Brexpiprazole Tablets